CEO Peter Selin presents Kancera’s Q3 2023 Interim Report
CEO Peter Selin presents KANDOVA, Kancera’s ongoing clinical study in ovarian cancer
CEO Peter Selin presents Kancera’s Q3 2023 Interim Report
CEO Peter Selin presents KANDOVA, Kancera’s ongoing clinical study in ovarian cancer